ReviewFrontiers in oncology2018

Progresses and Perspectives of Anti-PD-1/PD-L1 Antibody Therapy in Head and Neck Cancers.

Bo Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.